| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Externe beoordelaar - External assesor, | |
| dc.contributor.author | Bosch, Julian | |
| dc.date.accessioned | 2023-09-06T10:08:05Z | |
| dc.date.available | 2023-09-06T10:08:05Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/45039 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | This study focused on developing a population pharmacokinetic (PK) model for carboplatin in both preterm and full-term neonates and young infants, which accounted for relevant demographic covariates, that, in the end, allowed for dose individualization. | |
| dc.title | Population pharmacokinetic modelling of carboplatin in preterm and term neonates and young infants: towards dose individualization | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Farmacie | |
| dc.thesis.id | 23583 | |
